Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

A cream with a specific hormone blocker increases hair growth in mice.

GLP-1RA therapy may increase the risk of hair loss.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

GLP-1 agonists may increase the risk of hair loss.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Pioglitazone combined with metformin or spironolactone improves PCOS symptoms and insulin resistance.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

G-1 promotes hair growth in female mice by activating specific signaling pathways.

GLP-1 agonists may help treat certain skin conditions.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.